Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

20 works

Work: The Role of Chemotherapy in Triple Negative Breast Cancer

  1. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

    Rebecca Dent, Maureen Trudeau, Kathleen I. Pritchard +7

    Article20075 citations
    ABI

  2. Triple-Negative Breast Cancer: Molecular Subtypes and New Targets for Therapy

    Brian D. Lehmann, Jennifer A. Pietenpol, Antoinette R. Tan

    Article20154 citations
    ABI

  3. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

    Patricia Cortazar, Lijun Zhang, Michael Untch +34

    Review article20144 citations
    ABI

  4. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

    Brian D. Lehmann, Joshua A. Bauer, Xi Chen +4

    Article20114 citations
    ABI

  5. Globocan 2000 : cancer incidence, mortality and prevalence worldwide

    Jacques Ferlay, Paola Pisani, Donald Maxwell Parkin

    Book20013 citations
    ABI

  6. Molecular Subtype of Breast Cancer Metastases Significantly Influences Patient Post-Relapse Survival

    Nicholas P. Tobin, J. Chuck Harrell, Søren Brage +5

    Article20143 citations
    ABI

  7. Pathological complete response in breast cancer – Authors' reply

    Patricia Cortazar, Charles E. Geyer, Luca Gianni +2

    Other20153 citations
    ABI

  8. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials

    Gϋnter von Minckwitz, Michael Untch, Eveline Nüesch +20

    Article20103 citations
    ABI

  9. Characteristics of triple-negative breast cancer

    Tim C. de Ruijter, Jürgen Veeck, Joep P.J. de Hoon +2

    Review article20103 citations
    ABI

  10. Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors

    Valentina Guarneri, Kristine Broglio, Shu‐Wan Kau +8

    Article20063 citations
    ABI

  11. Triple-Negative Breast Cancer: An Unmet Medical Need

    Clifford A. Hudis, Luca Gianni

    Review article20113 citations
    ABI

  12. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

    Thérese Sørlie, Charles M. Perou, Robert Tibshirani +14

    Article20013 citations
    ABI

  13. Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer

    Mark Ayers, W. Fraser Symmans, James Stec +15

    Article20043 citations
    ABI

  14. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

    Roman Rouzier, Charles M. Perou, W. Fraser Symmans +13

    Article20053 citations
    ABI

  15. Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

    Gabriel N. Hortobágyi

    Article20123 citations
    ABI

  16. Triple Negative Breast Cancer Pathologic Diagnosis and Current Chemotherapy Treatment Options

    Bernardo L. Rapoport, Simon Nayler, Georgia Demetriou +2

    Article20143 citations
    ABI

  17. Survival in triple-negative breast cancer (TNBC): Evidence from the SEER database 2010-2011.

    Rebecca Dent, Paul N. Mainwaring, Tira J. Tan +4

    Article20153 citations
    ABI

  18. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

    Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess +10

    Article20233 citations
    ABI

  19. Gene expression profiling predicts clinical outcome of breast cancer

    Laura Van 't Veer, Hongyue Dai, Marc Van De Vijver +67

    Article20022 citations
    ABI

  20. Untitled

    Other1 citations
    ABI